Cerity Partners LLC Purchases 13,233 Shares of Humana Inc. (NYSE:HUM)

Cerity Partners LLC boosted its position in shares of Humana Inc. (NYSE:HUM) by 72.0% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 31,605 shares of the insurance provider’s stock after acquiring an additional 13,233 shares during the quarter. Cerity Partners LLC’s holdings in Humana were worth $10,011,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in HUM. Creative Financial Designs Inc. ADV boosted its position in shares of Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after buying an additional 61 shares during the period. CarsonAllaria Wealth Management Ltd. boosted its holdings in Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 39 shares during the period. Atwood & Palmer Inc. bought a new position in Humana in the 3rd quarter valued at $29,000. Ashton Thomas Securities LLC purchased a new stake in Humana in the third quarter worth $31,000. Finally, Your Advocates Ltd. LLP lifted its position in shares of Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Price Performance

Shares of NYSE HUM opened at $295.49 on Wednesday. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $527.18. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market cap of $35.58 billion, a PE ratio of 26.17, a P/E/G ratio of 2.35 and a beta of 0.52. The business has a 50-day simple moving average of $276.28 and a two-hundred day simple moving average of $330.23.

Humana (NYSE:HUM) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, equities analysts expect that Humana Inc. will post 15.86 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.20%. Humana’s payout ratio is presently 31.36%.

Analyst Ratings Changes

A number of research analysts have recently commented on HUM shares. KeyCorp assumed coverage on shares of Humana in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. TD Cowen raised their target price on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Royal Bank of Canada lowered their price target on Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and raised their price objective for the stock from $247.00 to $308.00 in a report on Wednesday, November 6th. Finally, Stephens reiterated an “equal weight” rating and issued a $250.00 target price on shares of Humana in a report on Wednesday, October 9th. Twenty investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.